1. Home
  2. SMID vs CMPX Comparison

SMID vs CMPX Comparison

Compare SMID & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

HOLD

Current Price

$34.52

Market Cap

182.7M

Sector

Industrials

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.17

Market Cap

955.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMID
CMPX
Founded
1960
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.7M
955.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
SMID
CMPX
Price
$34.52
$5.17
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$13.44
AVG Volume (30 Days)
9.3K
1.9M
Earning Date
11-13-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
81.92
N/A
EPS
2.22
N/A
Revenue
$88,866,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.13
N/A
Revenue Growth
16.37
N/A
52 Week Low
$25.13
$1.33
52 Week High
$44.63
$5.86

Technical Indicators

Market Signals
Indicator
SMID
CMPX
Relative Strength Index (RSI) 48.69 51.85
Support Level $34.84 $4.79
Resistance Level $38.80 $5.57
Average True Range (ATR) 1.93 0.30
MACD -0.07 -0.02
Stochastic Oscillator 31.53 53.21

Price Performance

Historical Comparison
SMID
CMPX

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: